Taxus Clears Legal Hurdle As Judge Denies J&J/Cordis Injunction Request
This article was originally published in The Gray Sheet
Executive Summary
The arguments made by Boston Scientific and Johnson & Johnson/Cordis in the ongoing drug-eluting stent patent dispute both have merit, according to Wilmington, Del. federal court Judge Sue Robinson
You may also be interested in...
Drug-eluting stent litigation
Wilmington, Del. federal court schedules June 2005 hearing of patent infringement suits exchanged between Boston Scientific and Johnson & Johnson. Judge Sue Robinson rejected requests for injunctions against sales by both firms last November; however, she noted J&J has a "likelihood of success on the merits" of the case (1"The Gray Sheet" Dec. 1, 2003, p. 17)...
Drug-eluting stent litigation
Wilmington, Del. federal court schedules June 2005 hearing of patent infringement suits exchanged between Boston Scientific and Johnson & Johnson. Judge Sue Robinson rejected requests for injunctions against sales by both firms last November; however, she noted J&J has a "likelihood of success on the merits" of the case (1"The Gray Sheet" Dec. 1, 2003, p. 17)...
Cypher $470 Mil. Q4 Domestic Sales Double Size Of Cordis Unit
Cypher drug-eluting stent U.S. sales propelled a 99% Cordis revenue jump in the fourth quarter to $896 mil